查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428305

2024 年单细胞基因测序全球市场报告

Single-Cell Genome Sequencing Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

单细胞基因测序市场规模预计在未来几年将快速成长。预计到 2028 年将以 14.6% 的复合年增长率 (CAGR) 增长至 42.7 亿美元。预测期内的预期增长是由自体自体免疫疾病患病率增加、神经系统疾病发病率增加、政府倡议和资金增加、受託研究机构(CRO) 兴起以及单细胞 RNA定序推动的（这可能是由于人们越来越认识到scRNA-seq 的潜力。预测期内预计的主要趋势包括单细胞定序技术的进步、单细胞多体学技术的开发、加速进展的协作倡议、创新解决方案的引入以及主要企业之间的合作伙伴关係。

癌症发生率的预期增加预计将推动未来单细胞基因测序市场的成长。癌症是一组以不受控制的细胞生长为特征的多种疾病，是影响细胞分裂和正常细胞功能的基因变化的结果。这种疾病的特征是基因改变，单细胞基因测序对于揭示单一癌细胞水平的这些基因改变将具有无价的价值。例如，2023年1月，美国癌症协会报告称，2022年美国将新增约190万癌症病例，并有609,360例癌症相关死亡。预测显示进一步增加，预计新增癌症病例为 2,750 万，癌症死亡人数为 1,630 万。因此，癌症发生率的上升预计将推动单细胞基因测序市场的成长。

基因组资料的显着扩展为单细胞基因测序市场的持续成长做出了重大贡献。基因组资料包括与生物体基因组的结构和功能相关的资讯。透过单细胞定序产生的基因组资料呈指数级增长，为资料分析、解释和生物资讯工具的开发提供了机会，从而推动了市场成长。根据美国国家人类基因组研究 (NHGRI) 2022 年报告，基因组资料预计在未来 10 年内将达到 2 至 40Exabyte。因此，基因组资料的快速成长将推动单细胞基因测序市场的发展。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响
  • 市场促进因素/市场抑制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年市场规模与成长表现
  • 2023-2028、2033 年市场规模与成长预测

第六章市场区隔

  • 全球单细胞基因测序市场，按类型细分、实际和预测，2018-2023、2023-2028、2033
  • 装置
  • 试剂
  • 全球单细胞基因测序市场，依技术细分，实际与预测，2018-2023、2023-2028、2033
  • NGS
  • PCR
  • qPCR
  • 微阵列
  • MDA
  • 全球单细胞基因测序市场，依疾病领域细分、绩效与预测，2018-2023、2023-2028、2033
  • 癌症
  • 免疫学
  • 产前诊断
  • 神经生物学
  • 微生物学
  • 其他的
  • 全球单细胞基因测序市场，依应用细分、实际与预测，2018-2023、2023-2028、2033
  • 循环细胞
  • 细胞分化/重编程
  • 基因组变异
  • 亚群表征
  • 其他的
  • 全球单细胞基因测序市场，依最终用户细分，实际与预测，2018-2023、2023-2028、2033
  • 学术/研究机构
  • 生物技术和生物製药公司
  • 诊所
  • 其他的

第 7 章 区域与国家分析

  • 全球单细胞基因测序市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球单细胞基因测序市场（按国家/地区、绩效和预测）2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 单细胞基因测序市场竞争形势
  • 单细胞基因测序市场公司概况
    • F Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • DH Life Sciences LLC.
    • Becton Dickinson And Company（BD）
    • Agilent Technologies Inc.

第31章 其他大型创新公司

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN GmbH
  • Bio-Techne Corporation
  • BGI Genomics Co. Ltd.
  • Fulgent Genetics Inc.
  • 10x Genomics Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc.
  • Standard BioTools Inc.
  • Singleron Biotechnologies
  • MGI Tech Co. Ltd
  • GENEWIZ Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14149

Single-cell genome sequencing is a powerful method for detecting genomic changes such as copy number variations (CNVs) and point mutations, as well as revealing cell-to-cell heterogeneity in biological materials. It is employed to investigate both healthy and diseased physiology.

The main types of single-cell genome sequencing include instruments and reagents. Instruments refer to specialized equipment or devices used to perform the various steps involved in the sequencing process. Various technologies, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), quantitative polymerase chain reaction (qPCR), microarray, and multiple displacement amplification (MDA), are utilized in disease areas such as cancer, immunology, prenatal diagnosis, neurobiology, microbiology, and others. The applications encompass circulating cells, cell differentiation or reprogramming, genomic variation, subpopulation characterization, and others, serving academic research laboratories, biotechnology biopharmaceutical companies, clinics, and other related entities.

The single-cell genome sequencing market research report is one of a series of new reports from The Business Research Company that provides single-cell genome sequencing market statistics, including single-cell genome sequencing industry global market size, regional shares, competitors with a single-cell genome sequencing market share, detailed single-cell genome sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell genome sequencing industry. This single-cell genome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell genome sequencing market size has grown rapidly in recent years. It will grow from $2.17 billion in 2023 to $2.47 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth observed in the historical period can be attributed to the increased understanding of genetic heterogeneity, a rising demand for precision medicine, increased focus on cancer research, growth in the prevalence of infectious diseases, and increased healthcare spending.

The single-cell genome sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth in the forecast period can be attributed to the increasing prevalence of autoimmune diseases, rising occurrences of neurological disorders, growing government initiatives and funding, the rise of contract research organizations (CROs), and increasing awareness of the potential of single-cell RNA sequencing (scRNA-seq). Key trends expected in the forecast period include advancements in single-cell sequencing technologies, the development of single-cell multi-omics technologies, collaborative initiatives to accelerate advancements, the introduction of innovative solutions, and partnerships among key players.

The anticipated rise in cancer prevalence is expected to drive the growth of the single-cell genome sequencing market in the future. Cancer, a diverse group of diseases characterized by uncontrolled cell growth, is a result of genetic changes affecting cell division and normal cellular functions. The disease is marked by genetic alterations, and single-cell genome sequencing proves invaluable in revealing these genetic changes at the individual cancer cell level. For example, in January 2023, the American Cancer Society reported approximately 1.9 million new cancer cases and 609,360 cancer-related deaths in the US in 2022. Predictions indicate a further increase, with an estimated 27.5 million new cancer cases and 16.3 million cancer deaths projected by 2040. Consequently, the rising incidence of cancer is expected to be a driving factor for the growth of the single-cell genome sequencing market.

The remarkable expansion of genomic data is a substantial contributor to the ongoing growth of the single-cell genome sequencing market. Genomic data encompasses information related to the structure and function of an organism's genome. The exponential increase in genomic data generated through single-cell sequencing opens up opportunities for data analysis, interpretation, and the development of bioinformatics tools, fostering market growth. As per a 2022 report from the National Human Genome Research Institute (NHGRI), the genomic data is projected to reach between 2 and 40 exabytes within the next decade. Hence, the rapid surge in genomic data is poised to propel the single-cell genome sequencing market.

Technological advancements emerge as a noteworthy trend gaining traction in the single-cell genome sequencing market. Leading companies in the sector are dedicated to developing technologically advanced solutions to enhance their market position. For instance, in May 2023, Mission Bio Inc., a US-based company specializing in single-cell multi-omics platforms, introduced the Tapestri Genome Editing Solution. This end-to-end product for genome editing analysis is expected to be a more effective analytical tool for developing next-generation gene-edited drugs, offering single-cell insights capable of impacting efficacy and safety.

Major players in the single-cell genome sequencing market are concentrating on the development of single-cell proteomics, a nascent discipline seeking to understand the diversity of protein expression within individual cells. Integrating single-cell genomics with proteomics techniques allows for studying the relationship between genomic information and protein expression at the single-cell level. For example, in October 2023, Proteome Sciences plc, a UK-based biotechnology company, launched SysQuant SCP, a single-cell proteomics commercial service. Leveraging the capabilities of its TMTpro isobaric labelling reagents, SysQuant SCP generates and analyzes quantitative mass spectrometry data to uncover subtle variations in individual cells and within subpopulations of the same primary cell type. This data is expected to advance our understanding of biological drivers of heterogeneity and evolution in disease contexts and therapy responses, providing new targets for personalized medicine.

In August 2021, Illumina Inc., a US-based company specializing in sequencing and array technologies, acquired GRAIL for an undisclosed amount. This strategic acquisition aligns with Illumina's mission to revolutionize healthcare, including combating the COVID-19 epidemic and assisting cancer patients in finding suitable treatments. GRAIL, a US-based biotechnology company, offers whole-genome sequencing, whole-genome methylation sequencing, and ultra-deep targeted sequencing.

Major companies operating in the single-cell genome sequencing market report are F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

North America was the largest region in the single-cell genome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single-cell genome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single-cell genome sequencing market consists of revenues earned by entities by providing single-cell analysis, genetic heterogeneity study, identification of genomes of individual cells, and microbiomes and cancer study. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-cell genome sequencing market also includes sales of single cell kit, DNA sequencing instruments and single-cell sequencing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Cell Genome Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-cell genome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell genome sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single-cell genome sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Instruments; Reagents
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Quantitative Polymerase Chain Reaction (qPCR); Microarray; Multiple Displacement Amplification (MDA)
  • 3) By Disease Area: Cancer; Immunology; Prenatal Diagnosis; Neurobiology; Microbiology; Other Disease Areas
  • 4) By Application: Circulating Cells; Cell Differentiation Or Reprogramming; Genomic Variation; Subpopulation Characterization; Other Applications
  • 5) By End User: Academic Research Laboratories; Biotechnology Biopharmaceutical Companies; Clinics; Other End Users
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; DH Life Sciences LLC.; Becton Dickinson And Company (BD); Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Single-Cell Genome Sequencing Market Characteristics

3. Single-Cell Genome Sequencing Market Trends And Strategies

4. Single-Cell Genome Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Single-Cell Genome Sequencing Market Size and Growth

  • 5.1. Global Single-Cell Genome Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Single-Cell Genome Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Single-Cell Genome Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Single-Cell Genome Sequencing Market Segmentation

  • 6.1. Global Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Reagents
  • 6.2. Global Single-Cell Genome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Quantitative Polymerase Chain Reaction (qPCR)
  • Microarray
  • Multiple Displacement Amplification (MDA)
  • 6.3. Global Single-Cell Genome Sequencing Market, Segmentation By Disease Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer
  • Immunology
  • Prenatal Diagnosis
  • Neurobiology
  • Microbiology
  • Other Disease Areas
  • 6.4. Global Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Circulating Cells
  • Cell Differentiation Or Reprogramming
  • Genomic Variation
  • Subpopulation Characterization
  • Other Applications
  • 6.5. Global Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Laboratories
  • Biotechnology Biopharmaceutical Companies
  • Clinics
  • Other End Users

7. Single-Cell Genome Sequencing Market Regional And Country Analysis

  • 7.1. Global Single-Cell Genome Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Single-Cell Genome Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Single-Cell Genome Sequencing Market

  • 8.1. Asia-Pacific Single-Cell Genome Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Single-Cell Genome Sequencing Market

  • 9.1. China Single-Cell Genome Sequencing Market Overview
  • 9.2. China Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Single-Cell Genome Sequencing Market

  • 10.1. India Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Single-Cell Genome Sequencing Market

  • 11.1. Japan Single-Cell Genome Sequencing Market Overview
  • 11.2. Japan Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Single-Cell Genome Sequencing Market

  • 12.1. Australia Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Single-Cell Genome Sequencing Market

  • 13.1. Indonesia Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Single-Cell Genome Sequencing Market

  • 14.1. South Korea Single-Cell Genome Sequencing Market Overview
  • 14.2. South Korea Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Single-Cell Genome Sequencing Market

  • 15.1. Western Europe Single-Cell Genome Sequencing Market Overview
  • 15.2. Western Europe Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Single-Cell Genome Sequencing Market

  • 16.1. UK Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Single-Cell Genome Sequencing Market

  • 17.1. Germany Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Single-Cell Genome Sequencing Market

  • 18.1. France Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Single-Cell Genome Sequencing Market

  • 19.1. Italy Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Single-Cell Genome Sequencing Market

  • 20.1. Spain Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Single-Cell Genome Sequencing Market

  • 21.1. Eastern Europe Single-Cell Genome Sequencing Market Overview
  • 21.2. Eastern Europe Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Single-Cell Genome Sequencing Market

  • 22.1. Russia Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Single-Cell Genome Sequencing Market

  • 23.1. North America Single-Cell Genome Sequencing Market Overview
  • 23.2. North America Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Single-Cell Genome Sequencing Market

  • 24.1. USA Single-Cell Genome Sequencing Market Overview
  • 24.2. USA Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Single-Cell Genome Sequencing Market

  • 25.1. Canada Single-Cell Genome Sequencing Market Overview
  • 25.2. Canada Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Single-Cell Genome Sequencing Market

  • 26.1. South America Single-Cell Genome Sequencing Market Overview
  • 26.2. South America Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Single-Cell Genome Sequencing Market

  • 27.1. Brazil Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Single-Cell Genome Sequencing Market

  • 28.1. Middle East Single-Cell Genome Sequencing Market Overview
  • 28.2. Middle East Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Single-Cell Genome Sequencing Market

  • 29.1. Africa Single-Cell Genome Sequencing Market Overview
  • 29.2. Africa Single-Cell Genome Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Single-Cell Genome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Single-Cell Genome Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Single-Cell Genome Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Single-Cell Genome Sequencing Market Competitive Landscape
  • 30.2. Single-Cell Genome Sequencing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. DH Life Sciences LLC.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson And Company (BD)
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Single-Cell Genome Sequencing Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN GmbH
  • 31.4. Bio-Techne Corporation
  • 31.5. BGI Genomics Co. Ltd.
  • 31.6. Fulgent Genetics Inc.
  • 31.7. 10x Genomics Inc.
  • 31.8. Promega Corporation
  • 31.9. Takara Bio Inc.
  • 31.10. Oxford Nanopore Technologies PLC
  • 31.11. Pacific Biosciences of California Inc.
  • 31.12. Standard BioTools Inc.
  • 31.13. Singleron Biotechnologies
  • 31.14. MGI Tech Co. Ltd
  • 31.15. GENEWIZ Inc.

32. Global Single-Cell Genome Sequencing Market Competitive Benchmarking

33. Global Single-Cell Genome Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Single-Cell Genome Sequencing Market

35. Single-Cell Genome Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Single-Cell Genome Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Single-Cell Genome Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Single-Cell Genome Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer